Race Oncology Share Purchase Plan
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Racura Oncology
- AGM Presentations
- Breakthrough Zantrene Heart Protection Discovery
- University of Wollongong R&D Collaboration
- Race secures sixth US patent for Zantrene
- Race secures fifth US patent for Zantrene
Later from Racura Oncology
- Race Oncology Investor Presentation - November 2021
- Race Oncology: Notification regarding unquoted securities - RAC
- Expanded Heart Protection Discovery for Zantrene
- Race raises $29.7 million in oversubscribed SPP
- MD Anderson Preclinical AML Study on Zantrene Published
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology